Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hong Kong Business Reporter.
Press releases published on October 8, 2025
Macau Cultural Assets Exchange Joins China’s National Copyright Trade Alliance
New council membership strengthens cross-border IP cooperation and expands global copyright trading opportunities. MACAO, MACAO, October 8, 2025 /EINPresswire.com/ -- Recently, the Macau Cultural Assets Exchange (www.mce.mo) was invited by the National …
Chiang Mai Elephant Nature Park Suffers Through Thailand’s Tourism Slowdown
TripAdvisor-awarded Elephant Freedom Project in Chiang Mai champions ethical tourism and animal welfare during Thailand’s recovery. CHIANG MAI, CHIANG MAI, THAILAND, October 8, 2025 /EINPresswire.com/ -- As Thailand faces shifting global perceptions and …
Guoyu RWA Launches 100-City Initiative to Advance Real-World Asset Tokenization and Global Digital Finance
Singapore, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Guoyu RWA, a blockchain-driven initiative under Guoying Holdings (Hainan), is shaping the future of global digital finance through compliant, secure, and scalable real-world asset (RWA) tokenization. As part of …
Critical networks face stealthy intrusions, record-breaking DDoS attacks and rising cryptographic demands, according to Nokia study
Press Release Critical networks face stealthy intrusions, record-breaking DDoS attacks and rising cryptographic demands, according to Nokia study Nearly 2 in 3 telecom operators experienced at least one “living off the land” attack the past 12 months, and …
Francesco Ciancia Rejoins Stellantis to Lead Global Manufacturing
Francesco Ciancia Rejoins Stellantis to Lead Global Manufacturing AMSTERDAM, October 8, 2025 – Stellantis N.V. today announces that Francesco Ciancia will rejoin the Company on November 1 as Global Head of Manufacturing and a member of the Stellantis …
Cornish Metals Announces Update to Its Plans to Re-Domicile to the UK
VANCOUVER, British Columbia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSXV: CUSN) (“Cornish Metals”, “Cornish Canada” or the “Company”) is pleased to announce that, in connection with its previously announced intention to re-domicile from …
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
EINDHOVEN, the Netherlands, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries …
Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR
EINDHOVEN, Pays-Bas, 08 oct. 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société leader dans le domaine des neurotechnologies visant au développement de thérapies innovantes destinées à la restauration du mouvement, des fonctions et de …
Dubai to Host Second International Library and Publishing Summit 2025 Under the Theme “The Future of the Publishing Industry”
DUBAI, United Arab Emirates, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The Mohammed Bin Rashid Library has announced the second edition of the Dubai International Library and Publishing Summit 2025, taking place from 30 October to 1 November under the theme “The …
Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors AlphaMedixTM showed prolonged and clinically meaningful …
Communiqué de presse : AlphaMedixTM (212Pb-DOTAMTATE) a satisfait l’ensemble des critères d’évaluation principaux d’efficacité lors de l’essai de phase 2, démontrant des bénéfices cliniquement significatifs chez les patients atteints (...)
AlphaMedixTM (212Pb-DOTAMTATE) a satisfait l’ensemble des critères d’évaluation principaux d’efficacité lors de l’essai de phase 2, démontrant des bénéfices cliniquement significatifs chez les patients atteints de tumeurs neuroendocrines gastro-entéro- …
WaterConnect’s first development agreement targets water infrastructure in Kenya.
Kansas City, MO / Nairobi, Kenya, Oct. 08, 2025 (GLOBE NEWSWIRE) -- WaterConnect, the project development company founded by Water.org, has signed its first project development agreement with consortium partners Haskoning, RebelGroup, Private …
Digital News Publishers Association (DNPA) Adopts Magnite Access to Streamline Access to Premium Inventory and Audience Data
MUMBAI, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, and the Digital News Publishers Association (DNPA), which represents 22 of India’s leading news media publishers, today announced …
Rethinking the Agency Model, Luke Tobin’s Unusual Group Leads the Industry Reset
London EC1V 2NX, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Rethinking the Agency Model, Luke Tobin’s Unusual Group Leads the Industry Reset Luke Tobin’s Unusual Group is redefining agency exits with a new model designed to deliver fair value and long-term success. …
NANO Nuclear Energy Announces $400 Million Oversubscribed Private Placement of Common Stock Priced at the Market Under Nasdaq Rules
The offering was led by an initial investment from a preeminent asset manager alongside several new and existing institutional investors Company’s cash position expected to be approximately $600 million following closing New York, NY, Oct. 07, 2025 (GLOBE …
DOW DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Dow Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOW
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Dow Inc. (NYSE: DOW) between January 30, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the …
Esperion Announces Pricing of Public Offering of Common Stock
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for …